The presented package image matches the product design registered with the Ukrainian regulatory authorities.
If you have noticed any differences, please call us at +380 44 490 75 22
Dosage form
Tablets №20.
Active ingredient
1 tablet contains famotidine equivalent to 100% of the substance – 20 mg.
Indications
Benign gastric ulcer. Treatment of duodenum ulcer (treatment and prevention of relapse). Hypersecretive conditions such as Zollinger-Ellison syndrome. Treatment of gastroesophageal reflux disease (reflux esophagitis). Prevention of symptoms and erosions or ulceration associated with gastroesophageal reflux disease.

If you have information about any adverse effects or other drug-related problems, please fill in the form